Role of global surveillance in combating bacterial resistance

Drugs

Volumn 61, Issue 2, 2001, Pages 167-173

  Marchese, Anna ^a   Schito, Gian Carlo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; COMMUNITY CARE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; INFECTION; INTERNATIONAL COOPERATION; META ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; REVIEW; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; HUMANS; PROGRAM DEVELOPMENT; PUBLIC HEALTH; WORLD HEALTH;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 0035095659     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200161020-00002     Document Type: Review

References (48)

1. The challenges of emerging infectious diseases
2. World Health Organization strategy for emerging infectious diseases
3. Resistance to antibiotics
4. Inactivation of antibiotics and the dissemination of resistance genes
5. Introduction: Problems with antimicrobial resistance in Gram-positive cocci
6. Evolution and spread of SHV extended-spectrum β-lactamases in Gram-negative bacteria
7. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit
8. The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally
9. Editorial Response: Send in the clones …… don't bother, they're here
10. Antibiotic resistance in Streptococcus pneumoniae
11. Surveillance of Antimicrobial Resistance: The WHONET Program
12. Tn916 family conjugative transposons and dissemination of antimicrobial resistance determinants
13. Approaches to limiting emergence of antimicrobial resistance in bacteria in human populations
14. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s
15. The management of infections and antibiotic therapy: A European survey
16. Antibiotic treatment of community-acquired pneumonia in clinical practice: A European perspective
17. Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe
18. Consequence of bacterial resistance to antibiotics in medical practice
19. Decreased in antibiotic susceptibility or increase in resistance?
20. National Nosocomial Infections Surveillance (NNIS) system: Description of surveillance methods
21. Nosocomial infection rates in adult and paediatric intensive care units in the United States
22. Nosocomial bloodstream infections in the SCOPE Program: Antimicrobial resistance, species occurence, molecular testing results and laboratory testing accurancy
23. Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: Frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE Program
24. Inducible Amp C β-lactamase producing Gram-negative bacilli from bloodstream infections: Frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program
25. New group tracks hospital's drug-resistant bugs
26. Sireva: Surveillance of invasive Streoptococcus pneumoniae in Brazil (1993-1998): Molecular characterization of penicillin-resistant strains
27. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) study
28. A multicenter collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project
29. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens-findings of the Alexander Project 1992-1996
30. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY Antimicrobial Surveillance Program
31. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance program
32. International surveillance of bloodstream infections due to Candida species: Frequency of occurence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada and South America for the SENTRY program
33. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
34. Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY Surveillance Programme
35. Prevalence of aminoglycoside resistance in 20 European University Hospitals participating in the European SENTRY Antimicrobial Surveillance Programme
36. Assessing the quality of the Alexander Project
37. Chairman's introduction - The importance of good quality surveillance data today
38. Evolving resistance patterns of Streptococcus pneumoniae: A link with long-acting macrolide consumption?
39. Basing empiric treatment choices for respiratory tract infections on the results of the Alexander Project
40. A review of the role of antibiotic policies in the control of antibiotic resistance
41. Decline of erythromycin resistance of group A streptococci in Japan
42. Hungary sees an improvement in penicillin resistance
43. The effect of changes in the consumption of macrolides antibiotics on erythromycin resistance in group A streptococci in Finland
44. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study
45. Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander Project 1992-1996
46. Management of infections due to antibiotic-resistant Streptococcus pneumoniae
47. Clinical relevance of Streptococcus pyogenes resistance to macrolides in Italy
48. Evoluzione delle resistenze ai farmaci antimicrobici in Streptococcus pneumoniae circolante in Italia. Analisi dei dati dell'Osservatorio Epidemiologico Italiano (1998)